Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-25 @ 2:30 AM
NCT ID: NCT06614634
Eligibility Criteria: Inclusion Criteria: * Age ≥ 18 years. * Diagnosis of clinically stable coronary artery disease (CAD), defined as stable angina pectoris, a history of myocardial infarction, history of percutaneous coronary intervention, or coronary artery bypass graft surgery. * Classified as having a low to moderate risk of experiencing a new cardiac event, according to established risk stratification guidelines. * Possession of a smartphone and reliable internet access at home to facilitate participation in telehealth interventions. Exclusion Criteria: * Presence of severe ventricular arrhythmias during low to moderate exercise intensity or a documented history of myocardial ischemia, unstable angina, or abnormal exercise test results during initial evaluation. * Presence of a pacemaker or implantable cardioverter-defibrillator that may interfere with study protocols. * Hospitalization for any cardiac condition within the last 6 weeks prior to enrollment. * Evidence of residual coronary artery stenosis necessitating revascularization procedures. * Classification of heart failure as New York Heart Association (NYHA) Class IV, indicating severe functional limitations. * Diagnosis of untreated malignancy that could affect participation and outcomes. * Presence of orthopedic, neurological, or psychiatric disorders that may hinder assessment or engagement in prescribed exercise regimens.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT06614634
Study Brief:
Protocol Section: NCT06614634